Insider · CIK 0001848319
SR One Capital Fund I Aggregator LP
Files at DSGN (Design Therapeutics, Inc.). First filing Dec 20, 2022, latest Dec 20, 2022.
In brief
SR One Capital Fund I Aggregator LP files SEC Form 4 as 10% owner at DSGN (Design Therapeutics, Inc.). Since Dec 20, 2022, SR One Capital Fund I Aggregator LP has reported 1 open-market buy worth $7.6M and 0 open-market sells worth $0, the latest filed on Dec 20, 2022.
A track record needs three past buys with six months of prices behind them; SR One Capital Fund I Aggregator LP has 0, so none is measured yet.
The newest scored trade: bought $7.6M of DSGN on Dec 16, 2022, filed Dec 20, 2022, scored 58 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DSGN: Design Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Design Therapeutics, Inc. | $7.6M 900,000 shares | +16% | +11% from low-66% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 21, 2024 | ACLX Arcellx, Inc. | 504,263 0.96% of outstanding | $37M | Mar 21, 2024 | none |
| Dec 14, 2023 | ACLX Arcellx, Inc. | 504,263 1.04% of outstanding | $25M | Dec 14, 2023 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2022 | DSGN Design Therapeutics, Inc. | POpen-market purchase Common Stock | +500,000 | $8.28 | $4.1M | 6,126,476 | Dec 20, 2022 |
| Dec 19, 2022 | DSGN Design Therapeutics, Inc. | POpen-market purchase Common Stock | +360,000 | $8.63 | $3.1M | 6,486,476 | Dec 20, 2022 |
| Dec 20, 2022 | DSGN Design Therapeutics, Inc. | POpen-market purchase Common Stock | +40,000 | $8.14 | $325k | 6,526,476 | Dec 20, 2022 |
Questions about SR One Capital Fund I Aggregator LP
Answered from the filings on this page, as of the latest one.
Is SR One Capital Fund I Aggregator LP buying or selling?
Not in the last 12 months. SR One Capital Fund I Aggregator LP's latest open-market trade on SEC Form 4 was bought $7.6M of DSGN on Dec 16, 2022.
How did SR One Capital Fund I Aggregator LP's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and SR One Capital Fund I Aggregator LP has 0.
Where does SR One Capital Fund I Aggregator LP file Form 4?
SR One Capital Fund I Aggregator LP has filed Form 4 at DSGN (Design Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.